Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:15 AM
Study NCT ID:
NCT06744920
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2024-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-02-26
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-17
First Submit QC Date:
None
Study First Post Date:
2024-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-14
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED